Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement deficiency states and meningococcal disease

J Figueroa1, J Andreoni, P Densen

  • 1Department of Internal Medicine, University of Iowa College of Medicine, Iowa City.

Immunologic Research
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Diagnosis and Management of the Patient with Obesity: Position Statement of the Obesity and Sarcopenia Working Group of the Spanish Society of Rehabilitation and Physical Medicine].

Rehabilitacion·2026
Same author

[Rehabilitation in patients with obesity: Approach and role of the rehabilitation physician in management. Data from the survey by the Obesity and Sarcopenia Working Group of the Spanish Society of Rehabilitation and Physical Medicine].

Rehabilitacion·2025
Same author

Streamlining Global Germplasm Exchange: Integrating Scientific Rigor and Common Sense to Exclude Phantom Agents from Regulation.

Plant disease·2025
Same author

The effect of antenatal isoniazid preventive therapy on birth outcomes in Western Kenya.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same author

Novel edible toys as iron carrier to prevent iron deficiency of postweaned pigs.

Animal : an international journal of animal bioscience·2021
Same author

Transcriptional analysis of metabolic and virulence genes associated with biofilm formation in Piscirickettsia salmonis strains.

FEMS microbiology letters·2020
Same journal

Emapalumab plus conventional therapy with or without ruxolitinib for pediatric hemophagocytic lymphohistiocytosis: a single center retrospective study.

Immunologic research·2026
Same journal

Immunological spectrum in patients with thymoma: beyond good syndrome.

Immunologic research·2026
Same journal

Microbiome immune crosstalk in Sjögren's syndrome: mechanistic insights and translational perspectives.

Immunologic research·2026
Same journal

Immune checkpoint inhibitor-induced myasthenia gravis and myocarditis: a fatal immune-related adverse event.

Immunologic research·2026
Same journal

TRIM28 and TRIM32: multifaceted regulators of innate immunity and antiviral defence.

Immunologic research·2026
Same journal

Decoding PANoptosis: Crosstalk of cell death pathways in immunity and inflammation.

Immunologic research·2026
See all related articles

Individuals with late complement component deficiency (LCCD) are prone to meningococcal disease. Vaccination with capsular antigens is recommended to protect these high-risk individuals against infection.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Complement System Biology

Background:

  • Complement deficiency states highlight complement's role in host defense and associated diseases.
  • Late complement component deficiency (LCCD) individuals show a marked susceptibility to recurrent meningococcal disease.
  • Understanding complement's function in neisserial infections is crucial, particularly in LCCD.

Purpose of the Study:

  • To investigate the immune response in LCCD individuals to meningococcal infections.
  • To clarify the role of specific antibodies (anti-lipooligosaccharide and anticapsular) in protection.
  • To evaluate the efficacy of vaccination strategies for LCCD individuals.

Main Methods:

  • Analysis of antibody production (antilipooligosaccharide and anticapsular polysaccharide) in LCCD individuals.

Related Experiment Videos

  • In vitro assessment of bacterial killing in complement-sufficient systems.
  • Epidemiologic data review to assess protective immunity post-infection.

    • Main Results:

    • LCCD individuals produce higher levels of antilipooligosaccharide (LOS) antibody, capable of killing certain meningococci in vitro.
    • Despite anti-LOS antibody production, protective immunity is often lacking after infection in LCCD individuals.
    • Anticapsular antibodies provide protection via complement-dependent opsonophagocytosis, the primary complement-mediated defense available to LCCD individuals.

    Conclusions:

    • Vaccination with capsular antigens is a key strategy to protect LCCD individuals against meningococcal disease.
    • Targeting complement-mediated opsonophagocytosis through vaccination is vital for this high-risk group.
    • Further research into epitopic specificity of antibodies can refine understanding and therapeutic approaches.